Please select a video from the list below.
Plasma BNP Predicts 5-Year Overall Survival in PAH
Overall survival for PAH patients remains poor, in spite of developments in treatment. Predicting mortality risk in PAH patients may help determine patient therapeutic and management strategies. In this presentation, Dr. Raymond Benza discusses a recent publication that describes the utility of plasma concentration of BNP in predicting 5-year overall survival in PAH patients using data from the REVEAL registry.